A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention.

@article{Jang2012ACO,
  title={A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention.},
  author={Jiyoung Jang and Jihyang Lim and Kiyuk Chang and Yonggoo Kim and Myungshin Kim and Hae Il Park and Jayoung Kim and Soyoung Shin},
  journal={Journal of clinical laboratory analysis},
  year={2012},
  volume={26 4},
  pages={262-6}
}
INTRODUCTION VerifyNow P2Y12 is commonly used to measure responsiveness to clopidogrel. We sought to compare the results obtained from novel INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay to assess the clopidogrel resistance in patients undergoing percutaneous coronary intervention. METHODS A total of 255 patients undergoing percutaneous coronary… CONTINUE READING